CervoMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CervoMed and other ETFs, options, and stocks.

About CRVO

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain.

CEO

John J. Alam

CEOJohn J. Alam

Employees

Employees15

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1995

Founded1995

Employees

Employees15

CRVO Key Statistics

Market cap

54.13M

Market cap54.13M

Price-Earnings ratio

-2.78

Price-Earnings ratio-2.78

Dividend yield

—

Dividend yield—

Average volume

155.45K

Average volume155.45K

High today

$7.10

High today$7.10

Low today

$6.05

Low today$6.05

Open price

$7.09

Open price$7.09

Volume

739.66K

Volume739.66K

52 Week high

$20.63

52 Week high$20.63

52 Week low

$1.80

52 Week low$1.80

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CRVO. This list is generated using Robinhood data, and it’s not a recommendation.

SNDL

NIO

Tonix Pharmaceuticals

Castor Maritime

Tilray Brands

Ocugen, Inc

CervoMed

Why Robinhood?

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. Show more

CRVO Key Statistics

Analyst ratings

100%

People also own

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain.